NCT07196527View on ClinicalTrials.gov

Evaluation of the Clinical Efficacy of PURESSENTIEL Allergy Protection Nasal Spray (SNPA®) in House Dust Mite Allergic Rhinitis- ACARAY Study

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

February 1, 2027

Conditions
Allergic Disorder of Respiratory System
Interventions
DEVICE

Puressentiel Allergy Protection Nasal Spray

Crossover study after nasal provocation test (Dermatophagoides pteronyssinus)

DEVICE

Saline spray (0.65%)

Crossover study after nasal provocation test (Dermatophagoides pteronyssinus)

All Listed Sponsors
lead

Puressentiel

INDUSTRY

NCT07196527 - Evaluation of the Clinical Efficacy of PURESSENTIEL Allergy Protection Nasal Spray (SNPA®) in House Dust Mite Allergic Rhinitis- ACARAY Study | Biotech Hunter | Biotech Hunter